Biogen Idec logo

NICE final ‘yes’ for Biogen’s MS pill

August 27, 2014
Sales and Marketing Aubagio, Biogen, RMS, RRMS, gilenya

In final guidance published today NICE has recommended NHS funding of Biogen Idec’s new multiple sclerosis pill in patients with …

Merck Serono breaks ground in China with new plant

August 27, 2014
Manufacturing and Production, Sales and Marketing China, Merck Serono, manufacturing, metformin

Merck Serono has broken ground for its new pharmaceutical manufacturing facility in Nantong, China. The new facility, which will be …

Pfizer Xalkori

US rivals Pfizer and Merck team up for lung cancer

August 27, 2014
Medical Communications, Research and Development, Sales and Marketing Merck, NSCLC, Roche, Xalkori, melanoma, pembrolizumab

The two biggest rival US pharma firms have joined forces to help develop a new combination treatment for certain non-small …

UK nurse with Ebola given new drug in London

August 27, 2014
Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, zmapp

A British nurse was this weekend flown to a London hospital and is now being given an experimental drug after …

monge_maria

Miriam Monge to join Sartorius Stedim Biotech

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sartorius Stedim Biotech (SSB), a pharma and biotech supplier, today announced the appointment of Miriam Monge as director of marketing …

astrazeneca_sign_sky_14

AstraZeneca and Illumina in new partnership

August 26, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Illumina, NGS technology, next generation sequencing

AstraZeneca has announced that it will develop next generation sequencing (NGS) for companion diagnostic tests in a new partnership with …

astrazeneca_double_logo

AZ launches US digital tool ‘DoctorsNotes’ in US

August 26, 2014
Medical Communications, Sales and Marketing AstraZeneca, CME, CPD, apps, digital

AstraZeneca has launched a new online tool in the US called DoctorsNotes to help medical professionals keep better up to …

Merck logo

Merck and Advaxis team up on immuno-oncology

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development ASCO, Merck, immunology, pd-1, pembrolizumab

Advaxis and Merck have signed a research deal to investigational Merck’s PD-1 inhibitor pembrolizumab in combination with Advaxis’ listeria-based cancer …

nricciardi_asterias

Asterias Biotherapeutics adds two to board

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asterias Biotherapeutics, Pfizer

US biotech firm Asterias Biotherapeutics has confirmed the appointments of Andrew Arno and Natale Ricciardi to its board of directors. …

NICE and market access: time for reform?

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bristol-Myers Squibb, NICE, Yervoy, reform

Earlier in the year, at the ABPI’s annual conference, the UK pharma lobby group released a new report suggesting that …

roche_glass_building

Roche pays $8.3bn for InterMune

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche

Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …

eliquis image

Pfizer/BMS blood thinner gains new licence

August 22, 2014
Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin

Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …

Astrazeneca image

AstraZeneca shores up defences against Pfizer

August 22, 2014
Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger

AstraZeneca has been making a series of big deals over the past three months as it looks to close the …

dr-siddharth-chachad

ELC Group names new senior head

August 22, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Siddharth Chachad, elf group

UK regulatory affairs provider the ELC Group has confirmed the appointment of clinical pharmacologist Dr Siddharth Chachad as its head …

Wellcome Trust makes Ebola research investment

August 21, 2014
Research and Development, Sales and Marketing Africa, Ebola, Nigeria, deltas, welcome trust

The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment …

Paula Deen image

Celebrity-endorsed drug ads don’t work, says research

August 21, 2014
Medical Communications, Sales and Marketing advertising, bon jovi, dtc, healthcare marketing, paula deen, pharma

New research reveals the US system of using celebrity-endorsed drug adverts offer treatments more credibility but not influence when it …

warren_crawford

Masters Speciality Pharma hires head from Idis

August 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing masters speciality pharma, warren crawford

Masters Speciality Pharma has appointed Warren Crawford as a partner development director to lead and implement creative deal structures for …

GPs admit to wrongly prescribing antibiotics

August 20, 2014
Medical Communications, Sales and Marketing GPs, UK, doctors, longitude, prescribing, prize

Nearly half of British GPs surveyed have admitted to prescribing antibiotics unnecessarily due to uncertainty and a lack of diagnostic …

AstraZeneca image

AZ and Mitsubishi partner on diabetic nephropathy

August 20, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy

AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …

Sanofi image

FDA approves Sanofi’s new rare disease drug

August 20, 2014
Research and Development, Sales and Marketing Elelyso, Gaucher disease, Genzyme, Sanofi, eliglustat

Sanofi’s biologics unit Genzyme has been granted approval for a new drug to treat the rare genetic disorder Gaucher’s disease. …

The Gateway to Local Adoption Series

Latest content